WallStreetZenWallStreetZen

NASDAQ: IART
Integra Lifesciences Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Integra Lifesciences Holdings revenue was $1.61B for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $442.6M, up 16.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IART annual revenue was $1.6B, with 4.5% growth year-over-year.

IART past revenue growth

How has IART's revenue growth performed historically?

Company
4.47%
Industry
10.59%
Market
20.87%
IART's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IART's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IART's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IART revenue history

Current Revenue
$1.6B
Current Earnings
-$6.9M
Current Profit Margin
-0.4%

Be the first to know when IART announces revenue.

IART Revenue History By Year

IART Yearly RevenueIART RevenueIART ChangeIART Revenue Growth
2024-12-31$1.61B$68.95M+4.47%
2023-12-31$1.54B-$16.09M-1.03%
2022-12-31$1.56B$15.22M+0.99%
2021-12-31$1.54B$170.58M+12.43%
2020-12-31$1.37B-$145.69M-9.60%
2019-12-31$1.52B$45.12M+3.06%
2018-12-31$1.47B$284.21M+23.92%
2017-12-31$1.19B$196.16M+19.77%
2016-12-31$992.08M$109.34M+12.39%
2015-12-31$882.73M$86.02M+10.80%
2014-12-31$796.72M$99.89M+14.33%
2013-12-31$696.83M-$134.04M-16.13%
2012-12-31$830.87M$50.79M+6.51%
2011-12-31$780.08M$48.01M+6.56%
2010-12-31$732.07M$49.58M+7.26%
2009-12-31$682.49M$27.88M+4.26%
2008-12-31$654.60M$104.15M+18.92%
2007-12-31$550.46M$131.16M+31.28%
2006-12-31$419.30M$141.36M+50.86%
2005-12-31$277.94M$48.11M+20.93%
2004-12-31$229.83M$44.23M+23.83%
2003-12-31$185.60M$67.78M+57.52%
2002-12-31$117.82M$24.38M+26.09%
2001-12-31$93.44M$21.79M+30.42%
2000-12-31$71.65M$28.77M+67.11%
1999-12-31$42.88M$25.32M+144.15%
1998-12-31$17.56M$2.82M+19.09%
1997-12-31$14.75M$1.60M+12.15%
1996-12-31$13.15M$2.92M+28.54%
1995-12-31$10.23M$1.57M+18.10%
1994-12-31$8.66MN/AN/A

1 of 3

Integra Lifesciences Holdings Revenue FAQ

What was IART's revenue last quarter?

On Invalid Date, Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 2024 revenue of $442.65 million up 11.49% year over year. In the same quarter last year, Integra Lifesciences Holdings's revenue was $397.04 million.

What was Integra Lifesciences Holdings's revenue in 2024?

Integra Lifesciences Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $1.61 billion, a 4.47% increase year over year.

How much does Integra Lifesciences Holdings make in a day?

Based on Integra Lifesciences Holdings annual revenue for the past five years, IART makes an average of $4,177,579.18 per day.

What was Integra Lifesciences Holdings's annual revenue growth in the past year?

As of Q2 2025, Integra Lifesciences Holdings's revenue has grown 4.47% year over year. This is 6.11 percentage points lower than the US Medical Devices industry revenue growth rate of 10.59%. Integra Lifesciences Holdings's revenue in the past year totaled $1.61 billion.

How much does Integra Lifesciences Holdings make in a year?

Integra Lifesciences Holdings's revenue by year for the past five years is:
  • Integra Lifesciences Holdings's revenue for the twelve months ending Dec 31, 2024 was $1.61 billion, a 4.47% increase year over year.
  • Integra Lifesciences Holdings's annual revenue for Dec 31, 2023 was $1.54 billion, a 1.03% decrease from 2022.
  • Integra Lifesciences Holdings's annual revenue for 2022 was $1.56 billion, a 0.99% increase from 2021.
  • Integra Lifesciences Holdings's annual revenue for 2021 was $1.54 billion, a 12.43% increase from 2020.
  • Integra Lifesciences Holdings's annual revenue for 2020 was $1.37 billion, a 9.6% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.